Health
Promising new CAR T cell therapy results in exceptional patient recovery – News-Medical.Net
In a clinical trial evaluating a novel immunotherapy option for cancer treatment, a child with rhabdomyosarcoma, a form of muscle cancer, that had spread to the bone marrow, showed no detectable cancer following treatment with chimeric antigen receptor (CAR) …
Reviewed by Emily Henderson, B.Sc.Jul 15 2020
In a clinical trial evaluating a novel immunotherapy option for cancer treatment, a child with rhabdomyosarcoma, a form of muscle cancer, that had spread to the bone marrow, showed no detectable cancer following treatment with chimeric antigen receptor (CAR) T cells that were engineered to target the HER2 protein on the surface of the cancer cells.
The trial, conducted by researchers at Baylor College of Medicine, Texas Children’s Hospital and Hous…
-
Business21 hours agoBrokers name 3 quality ASX 200 shares to buy today
-
Noosa News17 hours agoFirst home buyers’ options to almost double under expanded Home Guarantee Scheme
-
Noosa News18 hours agoSun Spirit sculpture returns ahead of Swell Sculpture Festival
-
Business19 hours agoMorgans says these ASX shares could rise 30%+